Conference Coverage

Study Characterizes Spectrum of Somatic Mutations in Chronic Lymphocytic Leukemia


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

This study was supported by grants from the National Institutes of Health, the National Cancer Institute, the Melton and Rosenbach Funds, the Blavatnik Family Foundation, the Howard Hughes Medical Institute (via an Early Career Physician-Scientist Award), and the Damon Runyon Cancer Research Foundation. Dr. Wang said she had no relevant financial disclosures. Some of the coauthors said they were consultants to numerous pharmaceutical companies or owned stock in pharmaceutical companies. Other than employment by INSERM on the part of Dr. Bernard, neither he nor Dr. Ebert had any relevant financial disclosures to report.

Pages

Recommended Reading

DCIS Assay Predicts Recurrence Risk After Breast Surgery
MDedge Family Medicine
Clodronate Offered Modest Benefit for Breast Cancer Patients
MDedge Family Medicine
Panel Endorses Surveillance for Low-Risk Prostate Cancer
MDedge Family Medicine
Medicare Study Confirms Colonoscopy's Cancer Prevention Power
MDedge Family Medicine
ZO-FAST: Immediate Zoledronic Acid Beats Delayed Tx in Early Breast Cancer
MDedge Family Medicine
AVEREL: Avastin Defers Progression in HER2-Positive Metastatic Breast Cancer*
MDedge Family Medicine
Breast Cancer Vaccine Begins Phase III Trial
MDedge Family Medicine
Contralateral Prophylactic Mastectomy Ups Surgical Risk
MDedge Family Medicine
Early Thrombolysis Improves Long-term Outcomes After DVT
MDedge Family Medicine
Stem Cell Transplant: Physical, Mental Health Burdens Persist
MDedge Family Medicine